Literature DB >> 11888758

Selective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosis.

Hidetaka Wakiyama1, Douglas B Cowan, Yoshiya Toyoda, Miceline Federman, Sidney Levitsky, James D McCully.   

Abstract

OBJECTIVE: Mitochondrial ATP-sensitive potassium channels have been proposed to be myoprotective. The relevance and specificity of this mechanism in cardiac surgery was unknown. The purpose of this study was to examine the effects of the mitochondrial potassium ATP-sensitive channel opener diazoxide on regional and global myocardial protection using a model of acute myocardial infarction.
METHODS: Pigs (n=19) were placed on total cardiopulmonary bypass and then subjected to 30 min normothermic regional ischemia by snaring the left anterior descending coronary artery (LAD). The aorta was then crossclamped and cold blood Deaconess Surgical Associates cardioplegia (DSA; n=6) or DSA containing 50 microM diazoxide (DZX; n=6) was delivered via the aortic root and the hearts subjected to 30 min hypothermic global ischemia. The crossclamp and snare were removed and the hearts reperfused for 120 min.
RESULTS: No significant differences in preload recruitable stroke work relationship, Tau, proximal, distal or proximal/distal coronary flow, regional or global segmental shortening, systolic bulging or post-systolic shortening were observed within or between DSA and DZX hearts during reperfusion. Infarct was present only in the region of LAD occlusion in both DSA and DZX hearts. Infarct size (% of area at risk) was 33.6+/-2.9% in DSA and was 16.8+/-2.4% in DZX hearts (P<0.01 versus DSA). Apoptosis as estimated by TUNEL positive nuclei was 120.3+/-48.8 in DSA and was significantly decreased to 21.4+/-5.3 in DZX hearts. Myocardial infarct was located centrally within the area at risk in both DSA and DZX hearts but was significantly increased at borderline zones within the area at risk in DSA hearts.
CONCLUSIONS: The addition of diazoxide to cardioplegia significantly decreases regional myocardial cell necrosis and apoptosis in a model of acute myocardial infarction and represents an additional modality for achieving myocardial protection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888758      PMCID: PMC3711118          DOI: 10.1016/s1010-7940(01)01156-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  25 in total

1.  Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells.

Authors:  M Akao; A Ohler; B O'Rourke; E Marbán
Journal:  Circ Res       Date:  2001-06-22       Impact factor: 17.367

2.  Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function.

Authors:  R M Fryer; J T Eells; A K Hsu; M M Henry; G J Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-01       Impact factor: 4.733

3.  Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection.

Authors:  Y Toyoda; S Levitsky; J D McCully
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

4.  Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis.

Authors:  E Daugas; S A Susin; N Zamzami; K F Ferri; T Irinopoulou; N Larochette; M C Prévost; B Leber; D Andrews; J Penninger; G Kroemer
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

5.  Contractile function and Ca2+ transport system of myocardium in ageing.

Authors:  V V Frolkis; R A Frolkis; L S Mkhitarian; V G Shevchuk; V E Fraifeld; L G Vakulenko; I Syrový
Journal:  Gerontology       Date:  1988       Impact factor: 5.140

6.  Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion.

Authors:  B Stadler; J Phillips; Y Toyoda; M Federman; S Levitsky; J D McCully
Journal:  Ann Thorac Surg       Date:  2001-08       Impact factor: 4.330

7.  Differential role of sarcolemmal and mitochondrial K(ATP) channels in adenosine-enhanced ischemic preconditioning.

Authors:  Y Toyoda; I Friehs; R A Parker; S Levitsky; J D McCully
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

8.  Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning.

Authors:  Y Toyoda; V Di Gregorio; R A Parker; S Levitsky; J D McCully
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

9.  Diazoxide protects mitochondria from anoxic injury: implications for myopreservation.

Authors:  C Ozcan; E L Holmuhamedov; A Jahangir; A Terzic
Journal:  J Thorac Cardiovasc Surg       Date:  2001-02       Impact factor: 5.209

10.  Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction.

Authors:  M P Maxwell; D J Hearse; D M Yellon
Journal:  Cardiovasc Res       Date:  1987-10       Impact factor: 10.787

View more
  12 in total

1.  The effect of butorphanol postconditioning on myocardial ischaemia reperfusion injury in rats.

Authors:  Yun Wu; Jing Wan; Wen-Zhon Zhen; Liu-Fang Chen; Jia Zhan; Jian-Juan Ke; Zong-Ze Zhang; Yan-Lin Wang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-13

2.  Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition.

Authors:  Michael O Griffin; Miki Jinno; Lindsey A Miles; Francisco J Villarreal
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

3.  Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery.

Authors:  James D McCully; Hidetaka Wakiyama; Douglas B Cowan; Micheline Federman; Robert A Parker; Sidney Levitsky
Journal:  Ann Thorac Surg       Date:  2002-12       Impact factor: 4.330

4.  Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury.

Authors:  Akihiro Masuzawa; Kendra M Black; Christina A Pacak; Maria Ericsson; Reanne J Barnett; Ciara Drumm; Pankaj Seth; Donald B Bloch; Sidney Levitsky; Douglas B Cowan; James D McCully
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-25       Impact factor: 4.733

5.  Transcriptomic and proteomic analysis of global ischemia and cardioprotection in the rabbit heart.

Authors:  James D McCully; Monoj K Bhasin; Christian Daly; Manuel C Guerrero; Simon Dillon; Towia A Liberman; Douglas B Cowan; John D Mably; Francis X McGowan; Sidney Levitsky
Journal:  Physiol Genomics       Date:  2009-05-19       Impact factor: 3.107

6.  Cardioplegia and diazoxide modulate STAT3 activation and DNA binding.

Authors:  Yng-Ju Hsieh; Hidetaka Wakiyama; Sidney Levitsky; James D McCully
Journal:  Ann Thorac Surg       Date:  2007-10       Impact factor: 4.330

7.  Injection of isolated mitochondria during early reperfusion for cardioprotection.

Authors:  James D McCully; Douglas B Cowan; Christina A Pacak; Ioannis K Toumpoulis; Haripriya Dayalan; Sidney Levitsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

8.  Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening.

Authors:  Xiaohong Liu; Kai Sun; Ailin Song; Xiaoyun Zhang; Xu Zhang; Xiaodong He
Journal:  World J Surg Oncol       Date:  2014-12-19       Impact factor: 2.754

9.  Intracoronary Delivery of Mitochondria to the Ischemic Heart for Cardioprotection.

Authors:  Douglas B Cowan; Rouan Yao; Vamsidhar Akurathi; Erin R Snay; Jerusha K Thedsanamoorthy; David Zurakowski; Maria Ericsson; Ingeborg Friehs; Yaotang Wu; Sidney Levitsky; Pedro J Del Nido; Alan B Packard; James D McCully
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

10.  Tanshinone‑IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes.

Authors:  Yeqing Fang; Chengcheng Duan; Shaoyuan Chen; Zhenguo Liu; Bimei Jiang; Wen Ai; Lei Wang; Peiyi Xie; Hongcheng Fang
Journal:  Int J Mol Med       Date:  2021-07-02       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.